Market Overview

UPDATE: Jefferies Raises PT on Aetna Following Coventry Acquisition

Share:
Related AET
Worst Performing Industries For June 2, 2015
2 Analysts Diverge On Humana Recommendations
Humana Closes Divestiture of Concentra for $1.055 Billion - Analyst Blog (Zacks)

In a report published Thursday, Jefferies analyst David Windley reiterated a Buy rating on Aetna (NYSE: AET), and raised the price target from $69.00 to $74.00.

In the report, Jefferies noted, “We are raising our EPS projections to reflect the Coventry acquisition by 5-10c more than accretion guidance of $0.45-0.90 in 2014-15. The company's diversified business, strong execution, modest exposure to Exchange risk, and low-to-mid teens EPS growth make AET our favorite MCO. At 9.5x 2014E EPS, AET is second cheapest in the group with the most attractive risk/reward profile. Raising our PT to $74.”

Aetna closed on Wednesday at $60.29.

Latest Ratings for AET

DateFirmActionFromTo
May 2015Leerink SwannMaintainsOutperform
Apr 2015BarclaysMaintainsOverweight
Apr 2015Leerink SwannMaintainsOutperform

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: David Windley JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (AET)

Around the Web, We're Loving...